The APC-EPCR signalling pathways are the main mechanisms for APC’s beneficial effects in various autoimmune and inflammatory diseases, including type 1 diabetes [108], inflammatory arthritis [109], systemic lupus erythematosus (SLE), and lupus nephritis (LN) [110]. This evidence concerns the gene PROCR and lupus nephritis.